2016 News Releases

Webcast ImageWebcast - Live
AtriCure, Inc. at the Leerink Global Healthcare Conference
02/11/16 at 8:05 a.m. ET
AtriCure, Inc. at the Leerink Global Healthcare Conference
Thursday, February 11, 2016 8:05 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2016 | 2015 | 2014 | 2013 | 2012
DateTitle 
02/01/16AtriCure to Announce Fourth Quarter and Full Year 2015 Financial Results
WEST CHESTER, Ohio--(BUSINESS WIRE)--Feb. 1, 2016-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, will release its financial results for the fourth quarter and full year 2015 on Tuesday, February 23, 2016. AtriCure will host a conference call at 4:30 p.m. Eastern Time on Tuesday, February 23, 2016 to discuss its fourth quarter and full year 2015 financi... 
Printer Friendly Version
01/21/16AtriCure to Present at the Leerink Global Healthcare Conference
WEST CHESTER, Ohio--(BUSINESS WIRE)--Jan. 21, 2016-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that it will present at the Leerink Global Healthcare Conference at the Waldorf Astoria Hotel in New York on Thursday, February 11, 2016. Management is scheduled to present at 8:05 a.m. Eastern Time. A live audio webcast of the presentation may be accesse... 
Printer Friendly Version
01/19/16AtriCure Announces Approval for the AtriClip in Japan
Approval opens up a new market for the most widely implanted left atrial appendage occlusion device in the world WEST CHESTER, Ohio--(BUSINESS WIRE)--Jan. 19, 2016-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for its AtriClip™ product... 
Printer Friendly Version
01/11/16AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2015 Updates 2016 Guidance
MASON, Ohio--(BUSINESS WIRE)--Jan. 11, 2016-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced preliminary financial results for fourth quarter and full year 2015 and updated 2016 financial guidance. Preliminary and unaudited revenue for fourth quarter 2015 is expected to be approximately $35.9 million, reflecting growth of approximately 21.9% ... 
Printer Friendly Version